Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.
(H) Died In Committee
Email me when HB 1667 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 1667. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would force health benefit plans and prescription‑drug programs that receive manufacturer copay assistance to count that assistance against a patient’s drug cost, deductible or annual out‑of‑pocket maximum. It also updates insurance code sections dealing with contract language and cash‑discount cards. The measure failed in committee and did not become law.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 1667
3 free questions a day, no accountHistory
- Died In Committee
- Referred To State Affairs
Sponsors
- Tullos · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 1667 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1667 freeOr ask your AI assistant about HB 1667 directly:
Add to Claude, ChatGPT or Cursor